Bengaluru (Karnataka) [India], Sep 17 (ANI): Biocon Biologics Ltd (BBL) and Serum Institute Life Sciences (SILS) have announced a strategic alliance in a bid to make a significant impact on global healthcare through vaccines and biologics.
Indian shares scale peaks, eye 2% weekly jump as banks extend rally reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Biocon Biologics to offer 15% stake to Serum Institute unit for access to vaccines oann.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oann.com Daily Mail and Mail on Sunday newspapers.
Serum Institute to buy 15% stake in Biocon Biologics worth $4 9 Bn biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.